Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.

Katoh, Masuko; Nakayama, Izuma; Wainberg, Zev A; Shitara, Kohei; Katoh, Masaru

Katoh, Masuko; Nakayama, Izuma; Wainberg, Zev A; Shitara, Kohei; Katoh, Masaru.

Affiliation

Katoh M; M & M Precision Medicine, Tokyo, Japan.
Nakayama I; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Wainberg ZA; Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Katoh M; M & M Precision Medicine, Tokyo, Japan.

Clin Transl Med ; 14(6): e1736, 2024 Jun.

Article in En | MEDLINE | ID: mdl-38877656

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Receptor, Fibroblast Growth Factor, Type 2 / Claudins / Antibodies, Monoclonal Limits: Humans Language: En Journal: Clin Transl Med Year: 2024 Document type: Article Affiliation country: Japón

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google